At1g51820 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At1g51820 antibody; F19C24.23 antibody; T14L22.3Probable LRR receptor-like serine/threonine-protein kinase At1g51820 antibody; EC 2.7.11.1 antibody
Target Names
At1g51820
Uniprot No.

Target Background

Database Links

KEGG: ath:AT1G51820

STRING: 3702.AT1G51820.1

UniGene: At.52141

Protein Families
Protein kinase superfamily, Ser/Thr protein kinase family
Subcellular Location
Membrane; Single-pass type I membrane protein.

Q&A

What is At1g51820 and what is its significance in plant biology?

At1g51820 encodes a probable leucine-rich repeat receptor-like serine/threonine-protein kinase in Arabidopsis thaliana (Mouse-ear cress) . This protein belongs to the family of LRR-RLKs (leucine-rich repeat receptor-like kinases) that harbor an extracellular malectin-like (ML) domain in addition to leucine-rich repeats . These proteins are structurally similar to proteins from the symbiosis receptor-like kinase family and play significant roles in plant-pathogen interactions .

Studies have shown that At1g51820 is consistently upregulated during infection by biotrophic filamentous pathogens such as Hyaloperonospora arabidopsidis, suggesting its involvement in plant defense responses or potentially in the establishment of biotrophic relationships . The gene appears to have evolutionary significance, being identified as one of the first to have emerged from a common ancestor within its family . Homologous proteins can be found in other plant species, including cotton (Gossypium hirsutum) .

What experimental applications are appropriate for At1g51820 antibodies?

At1g51820 antibodies are primarily validated for ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot (WB) applications . These techniques allow researchers to detect and quantify At1g51820 protein in plant tissue samples.

When designing experiments using these antibodies, researchers should consider:

  • Sample preparation protocols that preserve protein structure and epitope accessibility

  • Positive and negative controls to validate antibody specificity

  • Appropriate blocking reagents to minimize background signals

  • Optimized antibody concentrations for specific applications

For Western blotting applications, HRP-conjugated secondary antibodies are commonly used for detection, providing excellent sensitivity for protein identification and quantification . The choice between different detection methods should be based on the required sensitivity and the available imaging equipment in your laboratory.

What factors should be considered when selecting an At1g51820 antibody for research?

When selecting an At1g51820 antibody, researchers should evaluate several critical parameters:

  • Antibody format and source: The commercially available At1g51820 antibody is a rabbit polyclonal antibody produced using recombinant Arabidopsis thaliana At1g51820 protein as the immunogen . Polyclonal antibodies typically recognize multiple epitopes, making them less vulnerable to epitope masking due to protein conformation changes .

  • Purification method: The antibody is antigen-affinity purified, which enriches for antibodies with the highest specificity and affinity toward the antigen of interest . This purification process significantly reduces non-specific interactions.

  • Species reactivity: The antibody is specifically reactive with Arabidopsis thaliana (Mouse-ear cress) . Cross-reactivity with other plant species should be empirically determined if working with different model organisms.

  • Independent verification: Check the literature for prior successful use of the antibody. Many commercial suppliers can provide assistance to researchers looking for this information .

  • Manufacturing source: Consider whether the antibody is manufactured by the supplier or purchased and resold. Purchasing directly from the manufacturer ensures complete control of manufacturing, quality control processes, and proper shipping and storage conditions .

What are the recommended storage and handling conditions for At1g51820 antibodies?

For optimal performance of At1g51820 antibodies, proper storage and handling are essential:

  • Storage temperature: Upon receipt, store at -20°C or -80°C to maintain antibody integrity .

  • Avoid repeated freeze-thaw cycles: These can lead to protein denaturation and reduced antibody activity .

  • Buffer composition: The antibody is typically provided in a liquid form with a storage buffer containing 0.03% Proclin 300 as a preservative, 50% Glycerol, and 0.01M PBS at pH 7.4 .

  • Working aliquots: Consider preparing small working aliquots to minimize freeze-thaw cycles when the antibody is needed for experiments.

  • Handling practices: Follow aseptic techniques when handling antibody solutions to prevent microbial contamination.

What optimization strategies are recommended for At1g51820 antibody in immunological techniques?

Optimizing At1g51820 antibody usage requires systematic approach to several experimental parameters:

For Western Blotting:

ParameterRecommended RangeOptimization Approach
Primary Antibody Concentration1.7-15 μg/mL (polyclonal)Test dilution series, starting at middle concentration
Incubation Time and TemperatureOvernight at 4°CCompare with shorter incubations at room temperature
Blocking Solution5% non-fat dry milk or BSATest both to determine which gives lower background
Secondary Antibody SelectionHRP-conjugated anti-rabbit IgGEnsure minimal cross-reactivity with plant proteins

For ELISA:

  • Begin with antibody concentrations in the range of 1.7-15 μg/mL as recommended for polyclonal antibodies .

  • Conduct preliminary studies testing a broad range of antibody concentrations to determine the optimal working dilution .

  • When comparing samples stained with different concentrations of the same antibody, maintain consistent incubation time and temperature .

  • Consider that polyclonal antibodies generally require lower working concentrations than monoclonal antibodies (1.7-15 μg/mL versus 5-25 μg/mL) .

Both antibody concentration and incubation conditions significantly impact signal specificity and background levels. While higher antibody concentrations may increase signal intensity, they can also elevate background noise. Conversely, lower concentrations may reduce background but potentially sacrifice detection sensitivity.

How can researchers effectively troubleshoot non-specific binding with At1g51820 antibodies?

Non-specific binding is a common challenge when working with plant samples due to the presence of endogenous enzymes and complex matrix effects. To address this issue:

  • Increase blocking efficiency: Extend blocking time or test alternative blocking reagents such as fish gelatin or commercial blocking solutions specifically designed for plant samples.

  • Optimize antibody concentration: Perform titration experiments to determine the minimum antibody concentration that provides specific signal detection without background .

  • Adjust washing conditions: Incorporate more stringent or frequent washing steps using buffers containing higher salt concentrations or mild detergents.

  • Pre-adsorb the antibody: Incubate the diluted antibody with proteins from non-target tissues to remove antibodies that might cross-react with unrelated plant proteins.

  • Sample preparation refinements: Improve protein extraction methods to reduce the presence of interfering compounds. Consider additional purification steps for complex plant samples.

  • Negative controls: Include samples where the primary antibody is omitted or replaced with non-immune serum from the same species to identify potential sources of background.

  • Knockout/knockdown validation: If available, include samples from plants with At1g51820 knocked out or down as a specificity control.

What methodological considerations are important when studying At1g51820's role in plant-pathogen interactions?

When investigating At1g51820's function in plant-pathogen interactions, several methodological aspects require careful attention:

  • Temporal expression analysis: At1g51820 has been observed to be consistently upregulated during pathogen infection . Design time-course experiments to capture early, intermediate, and late infection stages.

  • Spatial expression patterns: Implement techniques such as in situ hybridization or fluorescent reporter constructs to determine if At1g51820 expression is localized to specific tissues or infection sites.

  • Infection model standardization: Establish reproducible infection protocols with well-characterized pathogen strains and controlled inoculation methods.

  • Quantitative analysis approaches: Combine protein detection (Western blot/ELISA using At1g51820 antibodies) with transcript analysis (qRT-PCR) to correlate protein abundance with gene expression.

  • Functional studies: Consider complementary approaches such as:

    • Genetic manipulation (overexpression, knockout, or site-directed mutagenesis)

    • Protein interaction studies (co-immunoprecipitation with At1g51820 antibodies, yeast two-hybrid)

    • Subcellular localization during infection (immunofluorescence microscopy)

  • Physiological measurements: Correlate At1g51820 expression with physiological responses such as reactive oxygen species production, callose deposition, or hormonal changes.

  • Cross-species comparisons: Investigate the conservation of At1g51820 function across different plant species using comparative genomics and immunological approaches .

How can machine learning approaches enhance At1g51820 antibody-antigen binding prediction?

Recent advances in machine learning offer promising approaches for predicting antibody-antigen interactions relevant to At1g51820 research:

  • Library-on-library screening approaches: These methods probe many antigens against many antibodies to identify specific interacting pairs. Machine learning models can analyze these many-to-many relationships to predict target binding .

  • Out-of-distribution prediction challenges: Standard models face difficulties when predicting interactions with antibodies and antigens not represented in training data. Active learning strategies can address this limitation .

  • Cost-effective experimental design: Active learning algorithms can reduce costs by starting with a small labeled subset of data and iteratively expanding the labeled dataset in the most informative way. For At1g51820 antibody research, this approach reduced the number of required antigen mutant variants by up to 35% .

  • Improved experimental efficiency: The best algorithms tested for antibody-antigen binding prediction sped up the learning process by 28 steps compared to random baseline approaches .

  • Implementation considerations: When applying these methods to At1g51820 research, consider:

    • Training data quality and diversity

    • Feature selection for antibody and antigen representation

    • Model validation with experimental verification

    • Integration with structural biology approaches

These computational approaches can significantly enhance experimental design efficiency when working with At1g51820 antibodies, particularly for epitope mapping or when designing variant-specific antibodies.

What are the essential validation steps for confirming At1g51820 antibody specificity?

Rigorous validation is crucial for ensuring that At1g51820 antibodies are detecting the intended target with high specificity:

  • Western blot analysis: Verify that the antibody detects a protein of the expected molecular weight in Arabidopsis samples. At1g51820 encodes an LRR receptor-like kinase, so the detected protein should match the predicted size of this protein class .

  • Positive and negative controls: Include samples with known expression levels of At1g51820, such as:

    • Tissues infected with Hyaloperonospora arabidopsidis (should show increased expression)

    • Tissues from knockout/knockdown lines (should show reduced or absent signal)

    • Recombinant At1g51820 protein as a positive control

  • Immunoprecipitation followed by mass spectrometry: This approach can confirm that the antibody is capturing the intended protein by identifying the peptides present in the immunoprecipitated sample.

  • Peptide competition assay: Pre-incubate the antibody with the immunizing peptide or recombinant protein before application. This should eliminate specific binding if the antibody is truly specific.

  • Cross-reactivity assessment: Test the antibody against proteins from related plant species or closely related LRR-RLK family members to evaluate potential cross-reactivity.

  • Immunohistochemistry correlation: Compare antibody staining patterns with known expression patterns from transcript analysis or reporter gene studies.

  • Batch-to-batch consistency testing: When obtaining new lots of the same antibody, perform comparative analyses to ensure consistent performance across batches.

What quality control measures should be implemented for long-term At1g51820 antibody studies?

For longitudinal studies using At1g51820 antibodies, implementing standardized quality control measures ensures data consistency and reliability:

  • Reference sample inclusion: Maintain aliquots of a standardized positive control sample to test each new experiment.

  • Calibration curves: Develop standard curves using recombinant At1g51820 protein for quantitative applications.

  • Antibody performance monitoring: Regularly assess antibody performance metrics:

    • Signal-to-noise ratio

    • Detection sensitivity limits

    • Consistency of band pattern or staining

    • Background levels

  • Storage condition verification: Periodically test antibodies stored for extended periods against fresh antibody aliquots to detect potential degradation.

  • Documentation practices: Maintain detailed records of:

    • Antibody lot numbers

    • Exact experimental conditions

    • Instrument settings

    • Image acquisition parameters

    • Raw data storage

  • Statistical quality control: Implement Levey-Jennings charts or similar tools to monitor assay performance over time and identify trends or shifts in antibody performance.

  • Inter-laboratory validation: When possible, exchange samples with collaborating laboratories to verify consistency of results across different research settings.

What emerging techniques might enhance the utility of At1g51820 antibodies in plant research?

Several cutting-edge approaches show promise for expanding the applications of At1g51820 antibodies:

  • Advanced imaging techniques: Super-resolution microscopy and expansion microscopy can provide unprecedented spatial resolution for localizing At1g51820 in plant tissues during pathogen infection.

  • Single-cell applications: Adapting At1g51820 antibodies for single-cell protein analysis could reveal cell-specific expression patterns during pathogen responses.

  • Multiplex detection systems: Developing protocols for simultaneous detection of At1g51820 alongside other defense-related proteins would provide more comprehensive insights into signaling networks.

  • In vivo antibody-based biosensors: Engineering antibody-based fluorescent biosensors could enable real-time monitoring of At1g51820 dynamics in living plant tissues.

  • Proximity labeling approaches: Combining At1g51820 antibodies with proximity labeling techniques like BioID or APEX could identify novel interaction partners.

  • Antibody engineering: Creating recombinant antibody fragments with enhanced specificity or membrane permeability could overcome current technical limitations.

  • Cross-species antibody development: Designing antibodies that recognize conserved epitopes across plant species would facilitate comparative studies of LRR-RLK function in different hosts .

These innovative approaches, coupled with computational prediction methods , will likely accelerate our understanding of At1g51820's role in plant immunity and receptor-like kinase signaling networks.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.